Presidio Capital Management’s Neuronetics STIM Stock Holding History

Presidio Capital Management’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,127	Closed	-$16.1K	–	94
2026 Q1	$16.1K	Sell	11,127 -26,309	-70%	-$41.7K	﹤0.01%	78
2025 Q4	$51.7K	Buy	37,436 +25,625	+217%	+$53.6K	0.02%	74
2025 Q3	$32.2K	Buy	+11,811	New	+$42K	0.01%	69
2025 Q2	–	Sell	-11,995	Closed	-$44.1K	–	78
2025 Q1	$44.1K	Buy	+11,995	New	+$43.8K	0.02%	71

Other funds holding STIM

DJYG

David J. Yvars Group University Park, Florida $212M AUM 33.06% 1-Year Est. Return

MMA

Miracle Mile Advisors Los Angeles, California $8.53B AUM 21.43% 1-Year Est. Return

PWA

Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Presidio Capital Management's STIM Position: Q2 2026 in Review

Presidio Capital Management sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 11,127 shares — an estimated $16.1K sold.

Presidio Capital Management first reported a position in STIM in Q1 2025 and held it in 4 quarters. The position peaked at $51.7K in Q4 2025. 8 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

Presidio Capital Management reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
Presidio Capital Management sold 11,127 Neuronetics shares in Q2 2026, an estimated $16.1K.
Presidio Capital Management first reported a position in Neuronetics in Q1 2025 and held it in 4 quarters.
Presidio Capital Management's Neuronetics position peaked at $51.7K in Q4 2025.
8 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Presidio Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.